Holen Sie sich die Stockscreener-App
1.625
0.31%
-0.005
Schlusskurs vom Vortag:
$1.63
Offen:
$1.63
24-Stunden-Volumen:
28,613
Relative Volume:
0.43
Marktkapitalisierung:
$88.86M
Einnahmen:
$118.18M
Nettoeinkommen (Verlust:
$5.99M
KGV:
12.32
EPS:
0.1319
Netto-Cashflow:
$-12.91M
1W Leistung:
+0.62%
1M Leistung:
+3.50%
6M Leistung:
+26.95%
1J Leistung:
-4.97%
1-Tages-Spanne:
$1.55
$1.632
1-Wochen-Bereich:
$1.50
$1.69
52-Wochen-Spanne:
$1.17
$1.82
Intercure Ltd Stock (INCR) Company Profile
Vergleichen Sie INCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.625 | 88.86M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
143.28 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.165 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
434.04 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
Will InterCure Ltd. stock outperform international peersQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
What sentiment indicators say about InterCure Ltd. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
What technical models suggest about InterCure Ltd.’s comeback2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Is InterCure Ltd. stock recession proofTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
Short interest data insights for InterCure Ltd.2025 Top Decliners & Safe Swing Trade Setups - newser.com
Is it time to cut losses on InterCure Ltd.Quarterly Trade Review & Long-Term Safe Investment Ideas - newser.com
Sentiment analysis tools applied to InterCure Ltd.2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Analyzing net buyer seller activity in InterCure Ltd.2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Momentum divergence signals in InterCure Ltd. chart2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Trend analysis for InterCure Ltd. this week2025 Top Decliners & Safe Swing Trade Setups - newser.com
How to build a custom watchlist for InterCure Ltd.2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Long term hold vs stop loss in InterCure Ltd.Quarterly Portfolio Summary & Intraday High Probability Alerts - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for InterCure (NASDAQ:INCR) - MarketBeat
What MACD signals say about InterCure Ltd.Trade Signal Summary & Weekly High Return Stock Forecasts - newser.com
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewswire
Chart overlay techniques for tracking InterCure Ltd.Analyst Upgrade & Weekly High Conviction Ideas - newser.com
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow - MarketScreener
Intercure Reports First Half 2025 Results With NIS 130 Million In Revenue And Positive Operating Cash Flow - TradingView
InterCure Announces Strong First Half 2025 Results Amid Strategic Expansion - TipRanks
Using Bollinger Bands to evaluate InterCure Ltd.July 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
What drives InterCure Ltd stock priceTrendline Breakouts & Build Wealth With Strategy - earlytimes.in
What to expect from InterCure Ltd. in the next 30 daysShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Is InterCure Ltd. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Risk vs reward if holding onto InterCure Ltd.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Is InterCure Ltd. still worth holding after the dip2025 Volume Leaders & Real-Time Volume Analysis - newser.com
InterCure (NASDAQ:INCR) Shares Up 0.6% – Time to Buy? - Defense World
Can InterCure Ltd. rally from current levels2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):